Inovio Pharmaceuticals Inc. (NASDAQ:INO) changes shares on Tuesday trading session, with a change of -1.81% or -$0.37 shares. The trading starts at $20.38 and closed at $20.69 throughout the day. The trading session low price was $19.82 and day high was $21.06 on Tuesday, August 04. After the session, the Healthcare sector daily volume shifted to 10.56 million while its average volume is 35.72M. In other hand, the INO market cap reached to $3.42B. While, its current target price is $22.33.
On July 30, 2020, Inovio vaccine candidate shows promise in non-human study. According to the news reported on Reuters, Inovio Pharmaceuticals Inc said on Thursday its COVID-19 vaccine candidate was effective in protecting rhesus macaques from the virus 13 weeks after the last vaccination.
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is down -2.28% and down -2.94% for month. Its quarterly performance was 90.93% above, while its half year performance is up 447.57%. INO yearly performance stood at positive 646.88% and rise 515.61% for year-to-date. Current recommendation for Inovio Pharmaceuticals Inc. is 2.90.
Earnings per share or EPS is an important financial measure, which defines the profitability of a company. INO EPS (TTM) for 12-month is -1.17. EPS for this year is -15.40%, while for the next year its value is 1.28. Its EPS Q/Q reached 12.90%. It has an EPS of -14.60% down for past five years and for the next five years will be down 0.00%.
The insider ownership moved to 1.60% and institutional holding shifted to 26.00%.
The company posted an EPS (TTM) of -1.17. According to the most recent quarter report on (Jun 2020), 8 analysts estimated an average EPS of -0.17, while -0.3 EPS posted a year ago period. Analyst Estimated EPS for INO published in the report was -$0.18 – -$0.16 during the same period. Comparing with last year, the average estimated EPS was -0.3 which is lower than -0.26 which was posted for recent quarter EPS.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for INO rise 122.27% for period of 200 days. SMA for 50 days was 3.52% which is showing green signal, while SMA-20 was -13.44%. The moving average value for Inovio Pharmaceuticals Inc. (INO) is 12.23 and 22.54 for 200 and 50 days respectively.
Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in INO stock. On Jul 30, Kim Jong Joseph, Chief Executive Officer, sold 100,000 trading shares at the cost of $21.13, which valued at 2.11 million. On Jul 15, KIES PETER, CFO, sold 35,000 shares at the cost of $24.95, with total shares of 119,290. On Jun 30, KIES PETER, CFO, sold 35,000 shares at the cost of 26.50. After this transaction, KIES PETER total shares reached to 119,290 which valued at 0.93 million.